{"id":"trenbolone-hexahydrobenzylcarbonate","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Anabolic Agents","category":"pharmacology"},{"label":"Hormones","category":"pharmacology"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"parabolan","offLabel":[],"synonyms":["trenbolone hexahydrobenzylcarbonate","parabolan","trenbolone cyclohexylmethylcarbonate"],"timeline":[],"approvals":[],"brandName":"Parabolan","ecosystem":[],"mechanism":{"target":"Polymerase acidic protein, Androgen receptor","modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and the key to unlocking muscle growth is a hormone called testosterone. Parabolan is a synthetic key that fits into these locks, allowing it to stimulate muscle growth and development. This process can lead to increased muscle mass and strength, but it can also have negative effects on the body if used improperly.","oneSentence":"Parabolan works by binding to androgen receptors in the body, mimicking the effects of testosterone and promoting muscle growth and development.","technicalDetail":"Parabolan exerts its anabolic effects by binding to androgen receptors (AR) in target tissues, including skeletal muscle, leading to increased protein synthesis and muscle growth. This is achieved through the activation of the AR-mediated signaling pathway, which ultimately results in the transcription of genes involved in muscle protein synthesis and hypertrophy."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Trenbolone_hexahydrobenzylcarbonate","title":"Trenbolone hexahydrobenzylcarbonate","extract":"Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5065","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=trenbolone hexahydrobenzylcarbonate","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Trenbolone_hexahydrobenzylcarbonate","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T16:01:45.483369","biosimilars":[],"competitors":[{"drugName":"acetophenazine","drugSlug":"acetophenazine","fdaApproval":"1961-04-05","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"amiodarone","drugSlug":"amiodarone","fdaApproval":"1985-12-24","patentExpiry":"Mar 13, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"apalutamide","drugSlug":"apalutamide","fdaApproval":"2018-02-14","patentExpiry":"Sep 23, 2033","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"beclometasone dipropionate","drugSlug":"beclometasone-dipropionate","fdaApproval":"1976-05-12","relationship":"same-target"},{"drugName":"bicalutamide","drugSlug":"bicalutamide","fdaApproval":"1995-10-04","genericCount":13,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"bromocriptine","drugSlug":"bromocriptine","fdaApproval":"1978-06-28","patentExpiry":"Jun 7, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"budesonide","drugSlug":"budesonide","fdaApproval":"1994-02-14","patentExpiry":"Sep 9, 2036","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"clobetasol propionate","drugSlug":"clobetasol-propionate","fdaApproval":"1985-12-27","patentExpiry":"Nov 5, 2028","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"clomifene","drugSlug":"clomifene","fdaApproval":"1967-02-01","relationship":"same-target"},{"drugName":"clotrimazole","drugSlug":"clotrimazole","fdaApproval":"1975-02-03","patentExpiry":"May 26, 2042","patentStatus":"Patent protected","relationship":"same-target"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"trenbolone hexahydrobenzylcarbonate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"acetophenazine","brandName":"acetophenazine","genericName":"acetophenazine","approvalYear":"1961","relationship":"same-target"},{"drugId":"amiodarone","brandName":"amiodarone","genericName":"amiodarone","approvalYear":"1985","relationship":"same-target"},{"drugId":"apalutamide","brandName":"apalutamide","genericName":"apalutamide","approvalYear":"2018","relationship":"same-target"},{"drugId":"beclometasone-dipropionate","brandName":"beclometasone dipropionate","genericName":"beclometasone dipropionate","approvalYear":"1976","relationship":"same-target"},{"drugId":"bicalutamide","brandName":"bicalutamide","genericName":"bicalutamide","approvalYear":"1995","relationship":"same-target"},{"drugId":"bromocriptine","brandName":"bromocriptine","genericName":"bromocriptine","approvalYear":"1978","relationship":"same-target"},{"drugId":"budesonide","brandName":"budesonide","genericName":"budesonide","approvalYear":"1994","relationship":"same-target"},{"drugId":"clobetasol-propionate","brandName":"clobetasol propionate","genericName":"clobetasol propionate","approvalYear":"1985","relationship":"same-target"},{"drugId":"clomifene","brandName":"clomifene","genericName":"clomifene","approvalYear":"1967","relationship":"same-target"},{"drugId":"clotrimazole","brandName":"clotrimazole","genericName":"clotrimazole","approvalYear":"1975","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"NDDF":"005817","UNII":"BNJ7Y3JFF2","CHEBI":"CHEBI:134706","INN_ID":"2916","RXNORM":"1484278","UMLSCUI":"C0771657","ChEMBL_ID":"CHEMBL1698011","KEGG_DRUG":"D08627","DRUGBANK_ID":"DB11551","PUBCHEM_CID":"20055297","SNOMEDCT_US":"117059000","SECONDARY_CAS_RN":"10161-33-8","MESH_DESCRIPTOR_UI":"D014204"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Parabolan is a synthetic, injected anabolic-androgenic steroid (AAS) of the nandrolone group, specifically the C17β hexahydrobenzylcarbonate ester of trenbolone. It is a small molecule modality, classified under the brand names Parabolan and Hexabolan.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}